Point72 Hong Kong Ltd Invests $1.65 Million in Molina Healthcare, Inc. (NYSE:MOH)

Point72 Hong Kong Ltd purchased a new position in shares of Molina Healthcare, Inc. (NYSE:MOH) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 5,666 shares of the company’s stock, valued at approximately $1,649,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Tributary Capital Management LLC raised its stake in shares of Molina Healthcare by 76.1% during the 4th quarter. Tributary Capital Management LLC now owns 4,190 shares of the company’s stock worth $1,219,000 after purchasing an additional 1,811 shares in the last quarter. Smartleaf Asset Management LLC raised its stake in shares of Molina Healthcare by 123.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 347 shares of the company’s stock worth $100,000 after purchasing an additional 192 shares in the last quarter. SYM FINANCIAL Corp purchased a new stake in shares of Molina Healthcare during the 4th quarter worth about $249,000. Summit Trail Advisors LLC purchased a new stake in shares of Molina Healthcare during the 4th quarter worth about $452,000. Finally, Entropy Technologies LP raised its stake in shares of Molina Healthcare by 58.1% during the 4th quarter. Entropy Technologies LP now owns 4,594 shares of the company’s stock worth $1,337,000 after purchasing an additional 1,688 shares in the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare Stock Performance

MOH opened at $313.63 on Friday. The firm has a market capitalization of $17.00 billion, a P/E ratio of 15.35, a price-to-earnings-growth ratio of 1.06 and a beta of 0.63. The stock’s 50 day moving average price is $324.06 and its two-hundred day moving average price is $308.42. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $365.23.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The company had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same quarter last year, the firm earned $5.73 EPS. Molina Healthcare’s revenue for the quarter was up 12.2% compared to the same quarter last year. On average, equities analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Insider Transactions at Molina Healthcare

In related news, Director Richard M. Schapiro sold 669 shares of the firm’s stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the transaction, the director now owns 11,244 shares in the company, valued at $3,603,702. This trade represents a 5.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now owns 17,375 shares of the company’s stock, valued at $5,235,608.75. This trade represents a 5.44% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 89,169 shares of company stock valued at $28,520,995. 1.10% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

MOH has been the subject of a number of recent research reports. Wells Fargo & Company raised Molina Healthcare from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $295.00 to $372.00 in a research note on Wednesday, March 5th. Sanford C. Bernstein initiated coverage on Molina Healthcare in a report on Tuesday, April 22nd. They issued an “outperform” rating and a $414.00 target price for the company. Robert W. Baird reiterated a “neutral” rating and set a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. UBS Group lowered their price target on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a report on Friday, February 7th. Finally, Mizuho increased their price target on Molina Healthcare from $376.00 to $400.00 and gave the company an “outperform” rating in a report on Wednesday, April 9th. Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $365.38.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.